NCT05568043Completed
The Reducing REVISITS Study: A Cluster RCT
The Reducing Respiratory Emergency Visits Using Implementation Science Interventions Tailored to Setting (REVISITS) Study: A Cluster Randomized Trial
Source: ClinicalTrials.gov · Last updated 7 Jul 2026
Brief summary (registry, in English)
This type II hybrid effectiveness-implementation trial will concurrently study the comparative effectiveness of virtual vs. in-person COPD care transition programs implemented via virtual mentored implementation approaches with and without co-design methods. The investigators will enroll up to 24 randomized sites (with a goal minimum of 16 sites) to: * Deliver the COPD programs implemented via mentored support in collaboration with SHM Center for Quality Improvement. * Compare the effectiveness and penetration of virtual versus in-person COPD care transition programs implemented along with mentoring support with or without co-design. The investigators aim to determine which combined approach(es) is/are the most effective at implementing evidence-based COPD program interventions and decreasing COPD acute care revisits with the greatest overall impact and sustainability.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 384 (actual)
- First submitted
- 14 Jul 2022
- Start date
- 15 Feb 2022
- Primary completion date
- 31 Mar 2024
- Lead sponsor
- University of Chicago
- Diseases
- COPD
- NCT number
- NCT05568043
What you commit to
- Study type: Interventional
- Participants enrolled: 384
- From 15 Feb 2022 to the primary completion date, 31 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Since enrollment for Aim 2 will occur on a site/system-level, the inclusion of specific individuals who meet these criteria are not applicable since Aim 2 will only enroll hospital sites, not individuals. The sites the investigators enroll will represent diverse patient populations and geographical locations across the US.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Chicago Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
Related publications
- Contextual Assessments for Chronic Obstructive Pulmonary Disease Transition of Care Bundle Implementation Planning for the Reduce REVISITS Study: Rapid Sequential Explanatory Mixed Methods Approach.JMIR Hum Factors · 2026 · PMID 41773688
- Virtual Mentored Implementation to Improve Care Transitions in Chronic Obstructive Pulmonary Disease: Protocol for a Pragmatic Implementation Study.JMIR Res Protoc · 2026 · PMID 41529255
This page is information, not medical advice. Discuss any trial with your doctor.